AI-generated summary
The authors report a prospective clinical study of a 755-nm picosecond laser with a fractionated lens array in 24 enrolled patients with acne scars and Fitzpatrick skin types V and VI, with 17 completing 3-month follow-up. Blinded reviewers identified pretreatment and post-treatment photographs with agreement in 82.4% of cases, and all subjects showed physician-rated clinical improvement. The authors also state that no serious or unanticipated adverse events occurred.
- Participants
- 24
- Who or what was studied
- Patients with acne scars and Fitzpatrick skin types V and VI (mean age 33.9 years, 95.8% women)
- Wavelengths
- 755 nm
- Limits stated in the abstract
- The abstract describes a small single prospective study with 17 of 24 subjects completing follow-up and no control group reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.